MAPT and Alzheimer disease: Such a probability of aberrant non-translating ribosome-tau interactions might increase in AD, in which the mutated tau proteins (P301L tau mutant)3 and the differentially truncated forms of tau lose their affinity for microtubules, thus altering their subcellular localization and increasing the cytosolic tau concentration43–45.